Emla 5% is a medicine containing the active ingredient(s) lidocaine (lignocaine) + prilocaine. On this page you will find out more about Emla 5%, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: lidocaine (lignocaine) + prilocaine
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Emla 5% (with 10 Occlusive Dressings) cream, 5 x 5 g
Consumer Medicine Information leaflet:
No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.
What this medicine is for
Topical anesthesia of the skin prior to insertion of IV catheters, blood sampling, vaccination; superficial surgical procedures, including split skin grafting. Topical anaesthesia of leg ulcers to facilitate mechanical cleansing and debridement. Topical anaesthesia of genital skin prior to superficial surgical procedures or infiltration anaesthesia. Topical anaesthesia of the skin prior to minor superficial cosmetic procedures.
Table of characteristics
|Visual appearance||White soft homogenous cream|
|Route of administration||Topical|
5g x 1 with 2 occlusive dressings: Pharmacy Medicine (Over the counter)
5g x 5 with 10 occlusive dressings: Pharmacy Medicine (Over the counter)
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 1 results
EMLA Cream - myDr.com.au
EMLA Cream - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 1 results
Topical agents or dressings for reducing pain in venous leg ulcers | Cochrane
Venous leg ulcers are often painful, both during and between dressing changes, and during surgical removal of dead tissue (debridement). Dressings, topical creams and lotions have been promoted to reduce the pain of ulcers. Two trials tested a dressing containing ibuprofen, however, the pain measures and time frames reported were different. One trial indicated that pain relief achieved over 5 days with ibuprofen dressings could represent a clinically relevant reduction in pain. The other trial found no significant difference in the chance of pain relief, measured on the first night of treatment, for ibuprofen dressings compared with foam dressings. This trial, however, was small and participants were only followed for a few weeks, which may not be long enough to assess whether the dressing affects healing. There was evidence from five trials that a local anaesthetic cream (EMLA 5%) reduces the post-procedural pain of debriding leg ulcers but there was insufficient evidence regarding any side effects of this cream and its impact on healing.
Read more on Cochrane (Australasian Centre) website